22 October 2017
News and Views
Links and Services
A study in the International Journal of Colorectal Disease compares doublet chemotherapy with single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer.
The clinical benefit of first-line doublet chemotherapy compared to single-drug therapy (5FU) in
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors